Disarm Therapeutics
Cambridge
About Disarm Therapeutics
Disarm Therapeutics is a biotechnology company that creates disease-modifying therapeutics for patients with axonal degeneration. Its drugs prevent the loss of axons and treat neurological diseases including multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies that enable patients to avail treatment for acute diseases of the central, ocular, and peripheral nervous systems. Disarm Therapeutics was founded in 2016 and is headquartered in Cambridge, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $30.0M
- Funding stage: M&A
- Last round: Series A (Sep 2017)
- Website: disarmtx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/disarm-therapeutics-34687 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.